Lyell Wealth Management LP Has $3.34 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Lyell Wealth Management LP grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,350 shares of the healthcare conglomerate’s stock after purchasing an additional 470 shares during the period. Lyell Wealth Management LP’s holdings in UnitedHealth Group were worth $3,343,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. International Assets Investment Management LLC boosted its position in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after acquiring an additional 2,348,107 shares in the last quarter. Jennison Associates LLC boosted its position in shares of UnitedHealth Group by 49.3% during the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after acquiring an additional 1,195,352 shares in the last quarter. Mawer Investment Management Ltd. boosted its position in shares of UnitedHealth Group by 75.0% during the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after acquiring an additional 862,024 shares in the last quarter. California Public Employees Retirement System boosted its position in shares of UnitedHealth Group by 35.9% during the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after acquiring an additional 815,822 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in UnitedHealth Group by 20.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after purchasing an additional 623,631 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently issued reports on UNH. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Stephens reaffirmed an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, Piper Sandler boosted their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Trading Up 0.2 %

NYSE UNH traded up $1.12 during trading on Wednesday, reaching $487.30. 3,722,296 shares of the stock traded hands, compared to its average volume of 4,532,990. The firm has a market cap of $449.26 billion, a price-to-earnings ratio of 29.79, a price-to-earnings-growth ratio of 1.42 and a beta of 0.54. The stock’s 50-day moving average price is $486.90 and its 200 day moving average price is $514.57. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.26 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.54%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 45.97%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.